Arcutis Biotherapeutics Inc (ARQT) Insider Trading

Total insider buys:
  • $26,579,888.32
Total insider sells:
  • $23,313,583.80
Most recent insider trade:
  • March 4, 2024
Most active insider trader:
  • Todd Franklin Watanabe
Trader NameDateTitleAmountPriceTypeTotal Value
March 4, 2024Insider3,760$11.12Sell$41,811.20
Jan. 2, 2024Insider1,325$3.54Sell$4,690.50
Nov. 21, 2023Insider1,850$1.98Sell$3,663.00
Oct. 24, 2023Major Shareholder80,000$2.50Buy$200,000.00
Aug. 21, 2023Insider1,605$7.04Sell$11,299.20
May 31, 2023Insider1,830$7.80Sell$14,274.00
April 17, 2023Director8,500$13.97Sell$118,745.00
April 6, 2023Director8,500$12.01Sell$102,085.00
March 6, 2023SVP831$15.26Sell$12,681.06
March 6, 2023Insider2,435$15.26Sell$37,158.10
March 6, 2023CFO291$15.26Sell$4,440.66
March 2, 2023Insider5,472$15.83Sell$86,621.76
March 2, 2023SVP1,432$15.83Sell$22,668.56
March 2, 2023CFO1,434$15.83Sell$22,700.22
Feb. 28, 2023CFO416$16.17Sell$6,726.72
Feb. 28, 2023SVP936$16.17Sell$15,135.12
Feb. 28, 2023Insider2,343$16.17Sell$37,886.31
Feb. 15, 2023Director8,500$16.98Sell$144,330.00
Feb. 13, 2023Insider483$17.00Sell$8,211.00
Jan. 17, 2023Director8,500$13.72Sell$116,620.00
Jan. 3, 2023Insider1,475$15.01Sell$22,139.75
Dec. 7, 2022Insider1,000$17.06Sell$17,060.00
Nov. 21, 2022Insider1,720$18.19Sell$31,286.80
Nov. 7, 2022Insider1,000$18.00Sell$18,000.00
Oct. 7, 2022CEO1,000$19.51Sell$19,510.00
Oct. 4, 2022Director6,000$20.29Sell$121,740.00
Sept. 7, 2022CEO1,000$21.51Sell$21,510.00
Aug. 15, 2022Director6,000$24.80Sell$148,800.00
July 18, 2022N/A6,000$24.40Sell$146,400.00
July 18, 2022Director6,000$24.40Sell$146,400.00
July 8, 2022President and CEO1,500$25.00Sell$37,500.00
July 8, 2022Chief Technical Officer2,197$25.41Sell$55,825.77
July 6, 2022CEO1,000$22.07Sell$22,070.00
June 24, 2022Major Shareholder341,971$21.31Sell$7,287,402.01
June 2, 2022SVP1,795$19.73Sell$35,415.35
June 1, 2022Director2,500$20.62Sell$51,550.00
May 5, 2022CEO1,000$21.76Sell$21,760.00
May 2, 2022Director2,500$20.44Sell$51,100.00
April 21, 2022Insider2,197$20.42Sell$44,862.74
April 8, 2022Major Shareholder200,000$20.71Sell$4,142,000.00
April 6, 2022Major Shareholder333,204$20.69Sell$6,893,990.76
April 5, 2022CEO1,000$21.43Sell$21,430.00
April 1, 2022Director7,500$20.02Sell$150,150.00
March 9, 2022CEO300$17.00Sell$5,100.00
March 7, 2022CFO10$16.44Sell$164.40
March 7, 2022Insider30$16.44Sell$493.20
March 7, 2022CEO770$17.05Sell$13,128.50
March 4, 2022SVP993$16.86Sell$16,741.98
March 4, 2022Insider981$16.86Sell$16,539.66
March 4, 2022CFO293$16.86Sell$4,939.98
First«1 of 2»Last
  • Insiders are both buying and selling Arcutis Biotherapeutics Inc stock.

  • The insider traders at Arcutis Biotherapeutics Inc are: Todd Franklin Watanabe, Howard G Welgus, Bhaskar Chaudhuri, Scott L Burrows, Masaru Matsuda, Patrick Burnett, John W. Smither, Patricia A Turney, Orbimed Advisors Llc, Life Sciences Viii L Frazier, Jonathan Silverstein, Howard G. Welgus, David W. Osborne, David W Osborne, Watanabe Todd Franklin, Welgus Howard G., and OSBORNE DAVID W

  • The most active insider trader at Arcutis Biotherapeutics Inc is Todd Franklin Watanabe with 28 trades.

  • Orbimed Advisors Llc has sold the most Arcutis Biotherapeutics Inc stock with a total value of $25,610,794.78.

  • Jonathan Silverstein has bought the most Arcutis Biotherapeutics Inc stock with a total value of $28,659,776.64.

  • The most recent insider trade for Arcutis Biotherapeutics Inc was on March 4, 2024.

  • The single biggest insider buy for Arcutis Biotherapeutics Inc was from Jonathan Silverstein with a total value of $14,329,888.32 on Feb. 3, 2020.

  • The single biggest insider sell for Arcutis Biotherapeutics Inc was from Orbimed Advisors Llc with a total value of $7,287,402.01 on June 24, 2022.